Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 172 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Postprandial Glucose Clear all

Conditions: Type 1 Diabetes
Interventions: Apidra, Humalog, Novolog; Drug
Lead sponsor: University of Florida; Other
Eligibility: 9 Years to 14 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: DeLeon Springs, Florida

Conditions: Metabolic Syndrome
Interventions: Placebo, Grape seed extract; Dietary Supplement
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 2
States / cities: Davis, California • Mather, California

Conditions: Postprandial Hyperglycemia
Interventions: Resistant Starch; Dietary Supplement
Lead sponsor: Kansas State University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Manhattan, Kansas

Conditions: Impaired Glucose Tolerance
Interventions: Exenatide, Metformin; Drug
Lead sponsor: St. Paul Heart Clinic; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: Saint Louis Park, Minnesota • Saint Paul, Minnesota

Conditions: Type 2 Diabetes
Interventions: GIP, Modified GIP, Normal Saline; Drug
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Type 1 Diabetes
Interventions: Pramlintide acetate, Placebo; Drug · Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Type2 Diabetes
Interventions: Abbott Freestyle Libre Pro, LifeStyle; Device · Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 70 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Insulin Resistance
Interventions: sourdough bread 24, sourdough bread 48, sourdough bread 72, yeast bread; Other
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Type 2 Diabetes
Interventions: Cocoa polyphenols; Dietary Supplement
Lead sponsor: Arpita Basu; Other
Eligibility: 21 Years to 60 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Stillwater, Oklahoma

Conditions: Diabetes, Diabetes Mellitus, Type 1, Type1diabetes, Diabetes Mellitus
Interventions: YG1699, Dapagliflozin; Drug
Lead sponsor: Youngene Therapeutics Inc., Ltd.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: Nephrotic Syndrome, Lipodystrophy, Metabolic Syndrome, Healthy Volunteer, Diabetes, Metabolic Associated Steatotic Liver Disease
Interventions: High carb then high fat breakfast, High fat then high carb breakfast; Other
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetes Mellitus, Type 1
Interventions: Meal-Tagging App, Fitness Tracker; Other · Device
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 1 Diabetes Mellitus
Interventions: LY900014, Insulin Lispro, Insulin Glargine, Insulin Degludec; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 1 Year to 17 Years
Enrollment: 751 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 27
States / cities: Birmingham, Alabama • Tucson, Arizona • Los Angeles, California + 24 more

Conditions: Adiposity, Insulin Sensitivity, Impaired Glucose Tolerance, Metabolic Disturbance
Interventions: Hypercaloric, High Fat Diet; Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 20 Years to 45 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Type 1 Diabetes
Interventions: Liraglutide, Placebo; Drug
Lead sponsor: University at Buffalo; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Williamsville, New York

Conditions: Blood Sugar (Glucose) Control, Blood Vessel (Vascular) Dysfunction
Interventions: Whey protein powder, Control protein; Dietary Supplement
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 50 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Diabetes, Heart Diseases, Diet Habit, Diet Modification, Healthy, Obesity, Metabolism, Microbial Colonization
Interventions: Dietary Intervention; Other
Lead sponsor: Zoe Global Limited; Other
Eligibility: 18 Years and older
Enrollment: 250,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Needham, Massachusetts

Conditions: Gestational Diabetes, Pregnancy Complications, Pregnancy in Diabetic, Fetal Macrosomia
Interventions: Postprandial ambulation; Behavioral
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Postprandial Hyperglycemia, Type2 Diabetes, Blood Sugar; High
Interventions: Control, Isomaltodextrin Low Dose, Isomaltodextrin High Dose, GPC partially digestible maltodextrin, Resistant Starch Type 4; Other
Lead sponsor: Purdue University; Other
Eligibility: 22 Years to 60 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Blood Glucose, Dietary Fiber, Hunger
Interventions: 100% steel cut barley, 100% barley flakes, 50/50 rice-barley mix, 80/20 rice-barley mix, 100% rice, white bread; Other
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Blood Glucose, Insulin Sensitivity, Dietary Fiber
Interventions: Medium-fiber bar, High-fiber bar, Control bar (0 g fiber); Other
Lead sponsor: Midwest Center for Metabolic and Cardiovascular Research; Other
Eligibility: 18 Years to 65 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Boca Raton, Florida • Chicago, Illinois

Conditions: Diabetes Mellitus, Type 1
Interventions: Technosphere insulin; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 70 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Pregnancy
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 0 Years to 39 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Diabetes, Gestational, Pregnancy Complications, Glucose Metabolism Disorders, Glucose Intolerance During Pregnancy
Interventions: Inhaled Technosphere Insulin; Drug
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 5
States / cities: Santa Barbara, California • Aurora, Colorado • New York, New York + 2 more

Search by objective public record fields.

Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia

Grape Seed Extract and Postprandial Oxidation and Inflammation

Comparison of Different Types of Resistant Starch

The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes

GIP: Glucose-dependent Insulinotropic Peptide

Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM

Validation of Machine Learning Based Personalized Nutrition Algorithm to Reduce Postprandial Glycemic Excursions Among North American Individuals With Newly Diagnosed Type 2 Diabetes

Effects of Sourdough Fermentation Duration and Acid Development on Postprandial Blood Glucose in Prediabetic Adults

Cocoa Polyphenols and Postprandial Metabolism in Type 2 Diabetes

A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes

Effects of Meal Macronutrients on Postprandial Lipids

A Study of Technology to Improve Glucose Control in Participants With Type 1 Diabetes

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes

Metabolic Adaptations to High-fat Diet

Liraglutide in the Treatment of Type 1 Diabetes Mellitus

Whey Protein Effects on Gycemic Control and Vascular Function

Personalized Responses to Dietary Composition Trial 3

Timing of Ambulation and Infant Birth Weight in Gestational Diabetes

The Attenuating Effect of Soluble Fiber Consumption on Postprandial Glycemia in Humans

Barley and Rice Mixture Effects on Blood Glucose

A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Glucose and Insulin Responses

Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT Study

The Early and Late Contribution of Fasting and Postprandial Triglycerides on Newborn Subcutaneous and Intrahepatic Fat in Pregnancy

Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes